Healthcare Industry News: blood glucose
News Release - November 4, 2008
TysonBio Officially Announces Its Entry into IndiaNov 4, 2008--(HSMN NewsFeed)--Tyson Bioresearch Inc, has been a dedicated biotech firm specializing in advanced rapid in vitro immunodiagnostic test systems and electrical bio-sensing system, particularly the blood glucose monitoring systems for every day usage. At TysonBio, it’s a prime concern in taking a different approach to the diagnostic of diseases – one focused on developing, acquiring and commercializing devices to detect and monitor the disease without compromising patient’s quality of life. Today TysonBio with its official announcement of its entry into India is committed to provide an extensive range of products keeping in concern for safer, more effective diagnostic devices which will make a meaningful difference to millions. To further consolidate their versatile strategy, TysonBio appoints two key national distributors to address these focused distributions to national reaches, more oriented services and geographic priorities.
Lifeline Surgicals, headquartered in New Delhi, with years of Medical product distribution experience and an energetic marketing team, LifeLine establishes strong retailing network in North India. “Honest and Quality” is their faith to run the business and strive for continuously improvement and innovation for products in order to fulfill customer satisfaction.
Regenix Drugs, headquartered in Chennai, stands among an elite group of firms capable of serving the needs of the constantly expanding Medical demands. Their offices across India, which ensures expert staff with an intimate knowledge of each market readily available, their customer base is well structured. Regenix Drugs has experienced steady, consistent, progressive growth in sales revenue since its inception.
Derek Lhundup, the Country Manager for India, with his educational background from India itself and an accustomed to Indian culture one who apart from English and Mandarin also speaks fluent Hindi, is ready to rock the blood glucose Monitoring market in India. Derek shows his strong confidence towards the Indian Market. Noted, “TysonBio’s long-term strategies are to assure maximum customer’s satisfactions and continuous improvements. Right after appointment of channel partners, TysonBio will strive for market growth with best of performance, unsurpassed quality and competitive pricing, while benefiting aspects with flexible manufacturing resources planning and logistics”. Frequent conversations with medical professionals and their patients, financial analysts, media representative and their own employees, have helped TysonBio design a web site that they hope provides the information what common people would seek. This manufacturer showcases an ambition of winning the heart of patients as well as partners.
Source: Tyson Bioresearch
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.